<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=7929104" created="11/07/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>7929104</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Regulation of <term id="T1" lex="interleukin-2_receptor_alpha_chain_expression" sem="Other"><term id="T2" lex="interleukin-2_receptor_alpha_chain" sem="Protein_molecule">interleukin-2 receptor alpha chain</term> expression</term> and <term id="T3" lex="nuclear_factor.kappa_B_activation" sem="Other"><term id="T4" lex="nuclear_factor.kappa_B" sem="Protein_molecule">nuclear factor.kappa B</term> activation</term> by <term id="T5" lex="protein_kinase_C" sem="Protein_molecule">protein kinase C</term> in <term id="T6" lex="T_lymphocyte" sem="Cell_natural">T lymphocytes</term>.</sentence>
<event id="E1">
<type class="Gene_expression"/>
<theme idref="T2"/>
<clue>Regulation of interleukin-2 receptor alpha chain <clueType>expression</clueType> and nuclear factor.kappa B activation by protein kinase C in T lymphocytes.</clue>
</event>
<event id="E2">
<type class="Regulation"/>
<theme idref="T4"/>
<cause idref="T5"/>
<clue><clueType>Regulation</clueType> <linkTheme>of</linkTheme> interleukin-2 receptor alpha chain expression and nuclear factor.kappa B activation <linkCause>by</linkCause> protein kinase C <clueLoc>in T lymphocytes</clueLoc>.</clue>
</event>
<event id="E3">
<type class="Positive_regulation"/>
<theme idref="T4"/>
<cause idref="T5"/>
<clue>Regulation of interleukin-2 receptor alpha chain expression and nuclear factor.kappa B <clueType>activation</clueType> <linkCause>by</linkCause> protein kinase C <clueLoc>in T lymphocytes</clueLoc>.</clue>
</event>
<sentence id="S2">Autocrine role of <term id="T7" lex="tumor_necrosis_factor_alpha" sem="Protein_molecule">tumor necrosis factor alpha</term>.</sentence>
<event id="E4">
<type class="Regulation"/>
<cause idref="T7"/>
<clue><clueType>Autocrine role</clueType> <linkCause>of</linkCause> tumor necrosis factor alpha.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S3">The regulation of <term id="T8" lex="interleukin-2_receptor_alpha_chain_(IL-2R_alpha)_expression" sem="Other"><term id="T9" lex="interleukin-2_receptor_alpha_chain" sem="Protein_molecule">interleukin-2 receptor alpha chain</term> (<term id="T10" lex="IL-2R_alpha" sem="Protein_molecule">IL-2R alpha</term>) expression</term> and <term id="T11" lex="nuclear_factor_(NF)_activation" sem="Other"><term id="T12" lex="nuclear_factor" sem="Protein_family_or_group">nuclear factor</term> (<term id="A1" sem="Protein_family_or_group">NF</term>) activation</term> by <term id="T13" lex="protein_kinase_C" sem="Protein_molecule">protein kinase C</term> (<term id="T14" lex="PKC" sem="Protein_molecule">PKC</term>) in <term id="T15" lex="resting_T_cell" sem="Cell_natural">resting T cells</term>, has been studied.</sentence>
<event KT="Other" id="E5">
<type class="Gene_expression"/>
<theme idref="T10"/>
<clue>The regulation of interleukin-2 receptor alpha chain (IL-2R alpha) <clueType>expression</clueType> and nuclear factor (NF) activation by protein kinase C (PKC) in resting T cells, has been studied.</clue>
</event>
<event KT="Investigation" id="E6" uncertainty="probable">
<type class="Regulation"/>
<theme idref="E5"/>
<cause idref="T14"/>
<clue>The <clueType>regulation</clueType> <linkTheme>of</linkTheme> interleukin-2 receptor alpha chain (IL-2R alpha) expression and nuclear factor (NF) activation <linkCause>by</linkCause> protein kinase C (PKC) <clueLoc>in resting T cells</clueLoc>, has been <clueKT>studied</clueKT>.</clue>
</event>
<event KT="Other" id="E7" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="A1"/>
<cause idref="T14"/>
<clue>The regulation of interleukin-2 receptor alpha chain (IL-2R alpha) expression and nuclear factor (NF) <clueType>activation</clueType> <linkCause>by</linkCause> protein kinase C (PKC) <clueLoc>in resting T cells</clueLoc>, has been studied.</clue>
</event>
<sentence id="S4">Treatment of human <term id="T16" lex="resting_T_cell" sem="Cell_natural">resting T cells</term> with <term id="T17" lex="phorbol_ester" sem="Organic_compound_other">phorbol esters</term> strongly induced the expression of <term id="T18" lex="IL-2R_alpha" sem="Protein_molecule">IL-2R alpha</term> and the activation of <term id="T19" lex="NF.kappa_B" sem="Protein_molecule">NF.kappa B</term>.</sentence>
<event id="E9">
<type class="Gene_expression"/>
<theme idref="T18"/>
<clue>Treatment of human resting T cells with phorbol esters strongly induced the <clueType>expression</clueType> <linkTheme>of</linkTheme> IL-2R alpha and the activation of NF.kappa B.</clue>
</event>
<event id="E10">
<type class="Positive_regulation"/>
<theme idref="T19"/>
<clue>Treatment of human resting T cells with phorbol esters strongly induced the expression of IL-2R alpha and the <clueType>activation</clueType> <linkTheme>of</linkTheme> NF.kappa B.</clue>
</event>
<event Manner="High" id="E11">
<type class="Positive_regulation"/>
<theme idref="E9"/>
<cause idref="T17"/>
<clue><linkCause>Treatment</linkCause> of <clueLoc>human resting T cells</clueLoc> <linkCause>with</linkCause> phorbol esters <clueManner>strongly</clueManner> <clueType>induced</clueType> the expression of IL-2R alpha and the activation of NF.kappa B.</clue>
</event>
<event Manner="High" id="E12">
<type class="Positive_regulation"/>
<theme idref="E10"/>
<cause idref="T17"/>
<clue><linkCause>Treatment</linkCause> of <clueLoc>human resting T cells</clueLoc> <linkCause>with</linkCause> phorbol esters <clueManner>strongly</clueManner> <clueType>induced</clueType> the expression of IL-2R alpha and the activation of NF.kappa B.</clue>
</event>
<sentence id="S5">This activation was due to the translocation of <term id="T20" lex="p65" sem="Protein_molecule">p65</term> and <term id="T21" lex="c-Rel" sem="Protein_molecule">c-Rel</term> <term id="T22" lex="NF.kappa_B" sem="Protein_family_or_group">NF.kappa B proteins</term> from <term id="T23" lex="cytoplasmic_store" sem="Cell_component">cytoplasmic stores</term> to the nucleus, where they bound the <term id="T24" lex="kappa_B_sequence" sem="DNA_domain_or_region">kappa B sequence</term> of the <term id="T25" lex="IL-2R_alpha_promoter" sem="DNA_domain_or_region">IL-2R alpha promoter</term> either as <term id="T26" lex="p50.p65" sem="Protein_complex"><term id="A3" sem="Protein_molecule">p50</term>.<term id="A4" sem="Protein_molecule">p65</term></term> or as <term id="T27" lex="p50.c-Rel" sem="Protein_complex"><term id="A5" sem="Protein_molecule">p50</term>.<term id="T28" lex="c-Rel" sem="Protein_molecule">c-Rel</term></term> <term id="A2" sem="Protein_complex">heterodimers</term>.</sentence>
<event id="E13">
<type class="Localization"/>
<theme idref="T20"/>
<clue>This activation was due to the <clueType>translocation</clueType> <linkTheme>of</linkTheme> p65 and c-Rel NF.kappa B proteins <clueLoc>from cytoplasmic stores to the nucleus</clueLoc>, where they bound the kappa B sequence of the IL-2R alpha promoter either as p50.p65 or as p50.c-Rel heterodimers.</clue>
<comment>NER T22 MOD</comment></event>
<event id="E14">
<type class="Localization"/>
<theme idref="T21"/>
<clue>This activation was due to the <clueType>translocation</clueType> <linkTheme>of</linkTheme> p65 and c-Rel NF.kappa B proteins <clueLoc>from cytoplasmic stores to the nucleus</clueLoc>, where they bound the kappa B sequence of the IL-2R alpha promoter either as p50.p65 or as p50.c-Rel heterodimers.</clue>
</event>
<event KT="Analysis" id="E15">
<type class="Positive_regulation"/>
<theme idref="E10"/>
<cause idref="E13"/>
<clue><corefTheme>This activation</corefTheme> was <clueType><clueKT>due</clueKT></clueType> <linkCause>to</linkCause> the translocation of p65 and c-Rel NF.kappa B proteins from cytoplasmic stores to the nucleus, where they bound the kappa B sequence of the IL-2R alpha promoter either as p50.p65 or as p50.c-Rel heterodimers.</clue>
</event>
<event id="E16">
<type class="Binding"/>
<theme idref="T25"/>
<theme idref="T26" idref1="A2"/>
<clue>This activation was due to the translocation of p65 and c-Rel NF.kappa B proteins from cytoplasmic stores to the nucleus, where <corefTheme>they</corefTheme> <clueType>bound</clueType> the kappa B sequence of the IL-2R alpha promoter either <linkTheme>as</linkTheme> p50.p65 or as p50.c-Rel heterodimers.</clue>
<comment>CAUTION: as</comment></event>
<event id="E17">
<type class="Binding"/>
<theme idref="T25"/>
<theme idref="T27" idref1="A2"/>
<clue>This activation was due to the translocation of p65 and c-Rel NF.kappa B proteins from cytoplasmic stores to the nucleus, where <corefTheme>they</corefTheme> <clueType>bound</clueType> the kappa B sequence of the IL-2R alpha promoter either as p50.p65 or <linkTheme>as</linkTheme> p50.c-Rel heterodimers.</clue>
<comment>CAUTION: as</comment></event>
<sentence id="S6">Interestingly, all of those events were largely indirect and mediated by endogenously secreted <term id="T29" lex="tumor_necrosis_factor_alpha" sem="Protein_molecule">tumor necrosis factor alpha</term> (<term id="T30" lex="TNF_alpha" sem="Protein_molecule">TNF alpha</term>), as they were strongly inhibited by a <term id="T31" lex="neutralizing_anti-TNF_alpha_monoclonal_antibody" sem="Protein_molecule">neutralizing anti-<term id="T32" lex="TNF_alpha" sem="Protein_molecule">TNF alpha</term> monoclonal antibody</term>.</sentence>
<event id="E18">
<type class="Positive_regulation"/>
<theme idref="E14"/>
<cause idref="T30"/>
<clue>Interestingly, <corefTheme>all of those events</corefTheme> were largely indirect and <clueType>mediated</clueType> <linkCause>by</linkCause> endogenously secreted tumor necrosis factor alpha (TNF alpha), as they were strongly inhibited by a neutralizing anti-TNF alpha monoclonal antibody.</clue>
</event>
<event id="E118">
<type class="Positive_regulation"/>
<theme idref="E16"/>
<cause idref="T30"/>
<clue>Interestingly, <corefTheme>all of those events</corefTheme> were largely indirect and <clueType>mediated</clueType> <linkCause>by</linkCause> endogenously secreted tumor necrosis factor alpha (TNF alpha), as they were strongly inhibited by a neutralizing anti-TNF alpha monoclonal antibody.</clue>
</event>
<event id="E218">
<type class="Positive_regulation"/>
<theme idref="E17"/>
<cause idref="T30"/>
<clue>Interestingly, <corefTheme>all of those events</corefTheme> were largely indirect and <clueType>mediated</clueType> <linkCause>by</linkCause> endogenously secreted tumor necrosis factor alpha (TNF alpha), as they were strongly inhibited by a neutralizing anti-TNF alpha monoclonal antibody.</clue>
</event>
<event Manner="High" id="E19">
<type class="Negative_regulation"/>
<theme idref="E14"/>
<cause idref="T31"/>
<clue>Interestingly, all of those events were largely indirect and mediated by endogenously secreted tumor necrosis factor alpha (TNF alpha), as <corefTheme>they</corefTheme> were <clueManner>strongly</clueManner> <clueType>inhibited</clueType> <linkCause>by</linkCause> a neutralizing anti-TNF alpha monoclonal antibody.</clue>
</event>
<event Manner="High" id="E119">
<type class="Negative_regulation"/>
<theme idref="E16"/>
<cause idref="T31"/>
<clue>Interestingly, all of those events were largely indirect and mediated by endogenously secreted tumor necrosis factor alpha (TNF alpha), as <corefTheme>they</corefTheme> were <clueManner>strongly</clueManner> <clueType>inhibited</clueType> <linkCause>by</linkCause> a neutralizing anti-TNF alpha monoclonal antibody.</clue>
</event>
<event Manner="High" id="E219">
<type class="Negative_regulation"/>
<theme idref="E17"/>
<cause idref="T31"/>
<clue>Interestingly, all of those events were largely indirect and mediated by endogenously secreted tumor necrosis factor alpha (TNF alpha), as <corefTheme>they</corefTheme> were <clueManner>strongly</clueManner> <clueType>inhibited</clueType> <linkCause>by</linkCause> a neutralizing anti-TNF alpha monoclonal antibody.</clue>
</event>
<sentence id="S7">Furthermore, <term id="T33" lex="cyclosporin_A" sem="Organic_compound_other">cyclosporin A</term>, which blocked <term id="T34" lex="TNF_alpha_production" sem="Other"><term id="T35" lex="TNF_alpha" sem="Protein_molecule">TNF alpha</term> production</term> induced by <term id="T36" lex="PKC" sem="Protein_molecule">PKC</term>, strongly inhibited <term id="T37" lex="IL-2R_alpha" sem="Protein_molecule">IL-2R alpha</term> and <term id="T40" lex="NF.kappa_B_activation" sem="Other"><term id="T41" lex="NF.kappa_B" sem="Protein_complex">NF.kappa B</term> activation</term>.</sentence>
<event KT="Other" id="E20">
<type class="Gene_expression"/>
<theme idref="T35"/>
<clue>Furthermore, cyclosporin A, which blocked TNF alpha <clueType>production</clueType> induced by PKC, strongly inhibited IL-2R alpha and NF.kappa B activation.</clue>
<comment>NER T37, T41 MOD, T38, T39 DEL</comment></event>
<event KT="Other" id="E21">
<type class="Positive_regulation"/>
<theme idref="E20"/>
<cause idref="T36"/>
<clue>Furthermore, cyclosporin A, which blocked TNF alpha production <clueType>induced</clueType> <linkCause>by</linkCause> PKC, strongly inhibited IL-2R alpha and NF.kappa B activation.</clue>
</event>
<event id="E22">
<type class="Negative_regulation"/>
<theme idref="E21"/>
<cause idref="T33"/>
<clue>Furthermore, cyclosporin A, which <clueType>blocked</clueType> TNF alpha production induced by PKC, strongly inhibited IL-2R alpha and NF.kappa B activation.</clue>
</event>
<event Manner="High" id="E23">
<type class="Negative_regulation"/>
<theme idref="T37"/>
<cause idref="T33"/>
<clue>Furthermore, cyclosporin A, which blocked TNF alpha production induced by PKC, <clueManner>strongly</clueManner> <clueType>inhibited</clueType> IL-2R alpha and NF.kappa B activation.</clue>
</event>
<event KT="Other" id="E24">
<type class="Positive_regulation"/>
<theme idref="T41"/>
<clue>Furthermore, cyclosporin A, which blocked TNF alpha production induced by PKC, strongly inhibited IL-2R alpha and NF.kappa B <clueType>activation</clueType>.</clue>
</event>
<event Manner="High" id="E25">
<type class="Negative_regulation"/>
<theme idref="E24"/>
<cause idref="T33"/>
<clue>Furthermore, cyclosporin A, which blocked TNF alpha production induced by PKC, <clueManner>strongly</clueManner> <clueType>inhibited</clueType> IL-2R alpha and NF.kappa B activation.</clue>
</event>
<sentence id="S8">The addition of either <term id="T42" lex="TNF_alpha" sem="Protein_molecule">TNF alpha</term> or <term id="T43" lex="IL-2" sem="Protein_molecule">IL-2</term> partially recovered <term id="T44" lex="cyclosporin_A" sem="Organic_compound_other">cyclosporin A</term>-induced <term id="T45" lex="IL-2R_alpha" sem="Protein_molecule">IL-2R alpha</term> inhibition, but only <term id="T46" lex="TNF_alpha" sem="Protein_molecule">TNF alpha</term> completely recovered <term id="T47" lex="NF.kappa_B" sem="Protein_molecule">NF.kappa B</term> activation.</sentence>
<event id="E26">
<type class="Negative_regulation"/>
<theme idref="T45"/>
<cause idref="T44"/>
<clue>The addition of either TNF alpha or IL-2 partially recovered cyclosporin A-<linkCause>induced</linkCause> IL-2R alpha <clueType>inhibition</clueType>, but only TNF alpha completely recovered NF.kappa B activation.</clue>
</event>
<event Manner="Low" id="E29">
<type class="Negative_regulation"/>
<theme idref="E26"/>
<cause idref="T42"/>
<clue>The <linkCause>addition of</linkCause> either TNF alpha or IL-2 <clueManner>partially</clueManner> <clueType>recovered</clueType> cyclosporin A-induced IL-2R alpha inhibition, but only TNF alpha completely recovered NF.kappa B activation.</clue>
</event>
<event Manner="Low" id="E30">
<type class="Negative_regulation"/>
<theme idref="E26"/>
<cause idref="T43"/>
<clue>The <linkCause>addition of</linkCause> either TNF alpha or IL-2 <clueManner>partially</clueManner> <clueType>recovered</clueType> cyclosporin A-induced IL-2R alpha inhibition, but only TNF alpha completely recovered NF.kappa B activation.</clue>
</event>
<event id="E31">
<type class="Positive_regulation"/>
<theme idref="T47"/>
<clue>The addition of either TNF alpha or IL-2 partially recovered cyclosporin A-induced IL-2R alpha inhibition, but only TNF alpha completely recovered NF.kappa B <clueType>activation</clueType>.</clue>
</event>
<event id="E32">
<type class="Positive_regulation"/>
<theme idref="E31"/>
<cause idref="T46"/>
<clue>The addition of either TNF alpha or IL-2 partially recovered cyclosporin A-induced IL-2R alpha inhibition, but only TNF alpha completely <clueType>recovered</clueType> NF.kappa B activation.</clue>
</event>
<sentence id="S9">Those results indicate that, in <term id="T48" lex="resting_T_cell" sem="Cell_natural">resting T cells</term>, <term id="T49" lex="PKC" sem="Protein_molecule">PKC</term> activation has only a triggering role, whereas the endogenously secreted <term id="T50" lex="TNF_alpha" sem="Protein_molecule">TNF alpha</term> plays an essential role in the <term id="T51" lex="quantitative_control" sem="Other">quantitative control</term> of the <term id="T52" lex="expression" sem="Other">expression</term> of <term id="T53" lex="IL-2R_alpha" sem="Protein_molecule">IL-2R alpha chain</term> or <term id="T54" lex="NF.kappa_B_activation" sem="Other"><term id="T55" lex="NF.kappa_B" sem="Protein_molecule">NF.kappa B</term> activation</term>.</sentence>
<event KT="Other" id="E33">
<type class="Positive_regulation"/>
<cause idref="T49"/>
<clue>Those results indicate that, <clueLoc>in resting T cells</clueLoc>, PKC <clueType>activation</clueType> has only a triggering role, whereas the endogenously secreted TNF alpha plays an essential role in the quantitative control of the expression of IL-2R alpha chain or NF.kappa B activation.</clue>
</event>
<event KT="Analysis" id="E133">
<type class="Positive_regulation"/>
<cause idref="E33"/>
<clue>Those results <clueKT>indicate</clueKT> that, <clueLoc>in resting T cells</clueLoc>, PKC activation <clueType>has only a triggering role</clueType>, whereas the endogenously secreted TNF alpha plays an essential role in the quantitative control of the expression of IL-2R alpha chain or NF.kappa B activation.</clue>
</event>
<event KT="Other" id="E34">
<type class="Gene_expression"/>
<theme idref="T53"/>
<clue>Those results indicate that, in resting T cells, PKC activation has only a triggering role, whereas the endogenously secreted TNF alpha plays an essential role in the quantitative control of the <clueType>expression</clueType> <linkTheme>of</linkTheme> IL-2R alpha chain or NF.kappa B activation.</clue>
<comment>NER T53 MOD</comment></event>
<event KT="Other" id="E35">
<type class="Positive_regulation"/>
<theme idref="T55"/>
<clue>Those results indicate that, in resting T cells, PKC activation has only a triggering role, whereas the endogenously secreted TNF alpha plays an essential role in the quantitative control of the expression of IL-2R alpha chain or NF.kappa B <clueType>activation</clueType>.</clue>
</event>
<event KT="Other" id="E36">
<type class="Regulation"/>
<theme idref="E34"/>
<clue>Those results indicate that, in resting T cells, PKC activation has only a triggering role, whereas the endogenously secreted TNF alpha plays an essential role in the quantitative <clueType>control</clueType> <linkTheme>of</linkTheme> the expression of IL-2R alpha chain or NF.kappa B activation.</clue>
</event>
<event KT="Other" id="E37">
<type class="Regulation"/>
<theme idref="E35"/>
<clue>Those results indicate that, in resting T cells, PKC activation has only a triggering role, whereas the endogenously secreted TNF alpha plays an essential role in the quantitative <clueType>control</clueType> <linkTheme>of</linkTheme> the expression of IL-2R alpha chain or NF.kappa B activation.</clue>
</event>
<event KT="Analysis" id="E38">
<type class="Positive_regulation"/>
<theme idref="E36"/>
<cause idref="T50"/>
<clue>Those results <clueKT>indicate</clueKT> that, <clueLoc>in resting T cells</clueLoc>, PKC activation has only a triggering role, whereas the endogenously secreted TNF alpha <clueType>plays</clueType> an essential <clueType>role</clueType> <linkTheme>in</linkTheme> the quantitative control of the expression of IL-2R alpha chain or NF.kappa B activation.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
